# New York — State drug price transparency reporting thresholds, triggers, and penalties for pharmaceutical manufacturers

For New York, price increase % trigger is more than 16%, including the proposed increase and the cumulative increases that occurred within the prior 24 months; reporting deadline is within 60 days of the planned effective date of an increase in price; statute is NY A1707, recorded from its source on 2026-08-14.

- **State:** New York
- **Price increase % trigger:** more than 16%, including the proposed increase and the cumulative increases that occurred within the prior 24 months _(verified: appears in the quote below)_
- **Reporting deadline:** within 60 days of the planned effective date of an increase in price _(verified: appears in the quote below)_
- **Statute:** NY A1707 _(verified: appears in the quote below)_

## What the source says

> NY A1707 requires manufacturers to file a notice within 60 days of the planned effective date of an increase in price for prescription drugs with a WAC of more than $40 for a course of therapy if the increase in WAC is more than 16%, including the proposed increase and the cumulative increases that occurred within the prior 24 months.

## Source

- https://www.goodwinlaw.com/en/insights/publications/2025/06/alerts-lifesciences-state-drug-transparency-laws

Last verified: 2026-08-14. Review by: 2027-02-10.
Part of [State drug price transparency reporting thresholds, triggers, and penalties for pharmaceutical manufacturers](https://referencesource.org/drug-price-transparency-thresholds/).